Lunit Company

Lunit, abbreviated from “learning unit,” is a venture company devoted to developing advanced software for medical data analysis and interpretation via cutting-edge deep learning technology. Our main area of expertise lies in processing medical imaging data. We envision a near-future when our systems would greatly help physicians make accurate, consistent, and efficient clinical decisions, not limited to diagnoses, through our data-driven imaging biomarker technology. The high level of our deep learning technology has been well demonstrated, ranked top 5 at ImageNet Challenge 2015, which is the world’s largest and most prestigious image recognition competition. What distinguishes our technology from that of other similar parties is full accommodation of weakly labeled data, challenging the boundaries of human understanding in terms of pattern recognition. Funded by major venture capital companies, Formation 8 and SoftBank Ventures Korea, our endeavors have been well received by the medical community alike and we are now engaged in various large-scale research partnerships with major university hospitals in Korea.
Technology: Biomarkers
Industry: Data processing
Headquarters: Seoul, Seoul-t'ukpyolsi, South Korea
Founded Date: 2013-01-01
Employees Number: 51-100
Funding Status: Late Stage Venture
Investors Number: 14
Total Funding: 133478911
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-11-29
Last Funding Type: Venture - Series Unknown

Visit Website
contact@lunit.io
https://twitter.com/Lunit_AI
Register and Claim Ownership